Clinical Trials Browser

Colorectal Neoplasms

Advanced Metastatic Colorectal Cancer

Hepatocellular Carcinoma Resectable

Liver, Cancer of, Primary Resectable

Colorectal Neoplasms

Carcinoma, Hepatocellular

Advanced Colorectal Carcinoma

Advanced Colorectal Cancer

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Colorectal Neoplasms

Colorectal Neoplasms

Thrombocytopenia, Colorectal Neoplasms

Stomach Neoplasms

Colonic Neoplasms

Colorectal Cancer Metastatic

Colorectal Neoplasms

Colon Cancer Liver Metastasis

Head and Neck Squamous Cell Cancer

Colorectal Neoplasms

Advanced Gastric Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Stomach Neoplasms

Inoperable Esophageal Cancer Stage I-III

Clinical Trials

Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy

SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients

Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma

Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer

Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer

Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus

The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer

Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.

A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer

RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)

Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia

Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection

Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer

TACE

Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients

Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases

Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer

Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer

A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer